BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19140230)

  • 1. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
    Cheon CW; Kim DH; Kim DH; Cho YH; Kim JH
    World J Gastroenterol; 2009 Jan; 15(3):310-20. PubMed ID: 19140230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
    Kang DW; Choi CH; Park JY; Kang SK; Kim YK
    Neurochem Res; 2008 Mar; 33(3):551-61. PubMed ID: 17940898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells.
    Chen HM; Zhang DG; Wu JX; Pei DS; Zheng JN
    Asian Pac J Cancer Prev; 2014; 15(5):2313-8. PubMed ID: 24716976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
    Akinyeke TO; Stewart LV
    Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
    Chana RS; Lewington AJ; Brunskill NJ
    Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.
    Rashid-Kolvear F; Taboski MA; Nguyen J; Wang DY; Harrington LA; Done SJ
    BMC Cancer; 2010 Jul; 10():390. PubMed ID: 20650001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis.
    Kang HY; Lee JY; Lee JS; Choi YM
    Arch Dermatol Res; 2006 Apr; 297(10):472-6. PubMed ID: 16474974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.
    Kim SH; Yoo CI; Kim HT; Park JY; Kwon CH; Kim YK
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):198-207. PubMed ID: 16616945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.
    Nagamine M; Okumura T; Tanno S; Sawamukai M; Motomura W; Takahashi N; Kohgo Y
    Cancer Sci; 2003 Apr; 94(4):338-43. PubMed ID: 12824901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ciglitazone inhibits growth of lung cancer cells A549 in vitro and in vivo: an experimental study].
    Zhang HL; Zhang ZX; Xu YJ
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):531-4. PubMed ID: 15555282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
    Lyles BE; Akinyeke TO; Moss PE; Stewart LV
    Cell Cycle; 2009 Jan; 8(2):268-77. PubMed ID: 19164938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.
    Colin-Cassin C; Yao X; Cerella C; Chbicheb S; Kuntz S; Mazerbourg S; Boisbrun M; Chapleur Y; Diederich M; Flament S; Grillier-Vuissoz I
    Mol Carcinog; 2015 May; 54(5):393-404. PubMed ID: 24293218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones.
    Dewar BJ; Gardner OS; Chen CS; Earp HS; Samet JM; Graves LM
    Mol Pharmacol; 2007 Nov; 72(5):1146-56. PubMed ID: 17686966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
    Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J
    Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
    Ming M; Yu JP; Meng XZ; Zhou YH; Yu HG; Luo HS
    World J Gastroenterol; 2006 Dec; 12(45):7263-70. PubMed ID: 17143939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
    Al-Alem L; Southard RC; Kilgore MW; Curry TE
    PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.